ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwieger, I. M.
Right arrow Articles by Maher, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwieger, I. M.
Right arrow Articles by Maher, K. L.

The Annals of Thoracic Surgery, Vol 48, 51-53, Copyright © 1989 by The Society of Thoracic Surgeons


ARTICLES

Incidence of Cell-Saver contamination during cardiopulmonary bypass

IM Schwieger, CJ Gallagher, DC Finlayson, WL Daly and KL Maher
Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia.

During regular bacteriological surveillance of cardiac surgical equipment and patients, the Cell Saver apparatus (CSA) was prospectively evaluated to determine if it represented an additional risk for infection. Nineteen patients were studied. After each operation, the effluent from the CSA was sterilely sealed for subsequent culture. A total of 42 aerobic and 42 anaerobic cultures were made. Postoperatively all patients were evaluated daily for four days and before discharge for clinical evidence of infection. Four patients had positive CSA cultures without evidence of postoperative clinical infection. Five patients in whom postoperative infectious complications developed had negative CSA cultures. Ten patients had negative CSA cultures and no evidence of postoperative infection. We conclude that the CSA does not appear to contribute to the risk of infection in cardiac surgical patients and that it is a safe adjunct to cardiac surgery.


This article has been cited by other articles:


Home page
ChestHome page
S. Dial, D. Nguyen, and D. Menzies
Autotransfusion of Shed Mediastinal Blood: A Risk Factor for Mediastinitis After Cardiac Surgery? Results of a Cluster Investigation
Chest, November 1, 2003; 124(5): 1847 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
C. Huth, A. Friedl, A. Rost, and for the GELIA Study Investigator Group
Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: analysis of the GELIA Database (GELIA 4)
Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q33 - Q38.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Reents, J. Babin-Ebell, M. R. Misoph, A. Schwarzkopf, and O. Elert
Influence of different autotransfusion devices on the quality of salvaged blood
Ann. Thorac. Surg., July 1, 1999; 68(1): 58 - 62.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The Society of Thoracic Surgeons.